News Briefs: DePuy ASR Settlement; Tandem Diabetes IPO; AtriCure Trial
This article was originally published in The Gray Sheet
Executive Summary
DePuy settles bulk of U.S. ASR suits. Tandem Diabetes closes $138 million IPO. AtriCure gets go-ahead for new AtriClip stroke. More news.